Sandbox: wdx causes: Difference between revisions

Latest revision as of 21:38, 17 September 2018

Differentiating Leukocytosis from Other Diseases

Category	Condition	Etiology	Mechanism				Congenital	Acquried	Clinical manifestations											Para−clinical findings								Gold standard	Associated findings
									Demography	History	Symptoms			Signs						Para−clinical findings
											Symptoms			Signs						Lab Findings
			Physiologic	Increased bone marrow production		Demargination of peripheral blood neutrophils					Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other	CBC			PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT
			Physiologic	Autonomous	Reactive	Demargination of peripheral blood neutrophils					Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT
Hematologic	Hereditary neutrophilia	Unknown Germline mutation in CSF3R	-	+	--	-	+	-	Rare autosomal dominant genetic disorder	Positive family history	Normal	-	-	Nl	-	+	-	-	-	↑	Nl	Nl	Normal granulocytes Histiocytes of Gaucher type	Nl	Nl	Nl	Nl	Genetic study	High leukocyte alkaline phosphatase Progress to leukemia
	Hereditary chronic neutrophilia
	Myeloproliferative neoplasms
	Polycythemia vera
	Microangiopathic hemolytic anemia (MAHA)
	Leukoerythroblastosis
	Immune thrombocytopenia
Immunology/ Rheumatology	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings
	Leukocyte adhesion deficiency
	Cryopyrin-associated periodic syndromes
	Rheumatoid arthritis
	Juvenile onset rheumatoid arthritis
	Adult Still's disease
	Kawasaki disease
	IBD
	Sarcoidosis
	Chronic hepatitis
	Sweet syndrome
	Acute gout
Infection	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings
	Acute bacterial																						toxic granulations, Döhle bodies, and cytoplasmic vacuoles in neutrophils
	Chronic infection
	Viral infection
	Granulomatous infections
	Bronchiectasis
Metabolic	Diabetic coma
	Acidosis
	Thyroid storm
	Hypercortisolism
	Seizures
Medication	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings
	Steriod	Release of granulocytes from the bone marrow
	Myeloid growth factors
	Lithium
	Cytokines
	Catecholamines (epinephrine)	Stimulation of bone marrow myelopoiesis Egress into the circulation
	ATRA
Other	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings
	Allergy
	Post splenectomy
	Down syndrome
	Cigarette smoking
	Stress/exercise
	Infancy
	Pregnancy
	Platelet clumping	Spurious
	Mixed cryoglobulinemia	Spurious
Category	Condition	Etiology	Physiologic	Autonomous increased bone marrow production	Reactive increased bone marrow production	Demargination of peripheral blood neutrophils	Congenital	Acquried	Demography	History	Appearance	Fever	Abdominal pain	BP	Asplenia	Hepatosplenomegaly	Lymphadenopathy	Joint redness	Other signs	WBC	HB	Plt	PBS	Bone marrow exam	ESR/CRP	BUN/Cr	LFT	Gold standard	Associated findings

@@ Line 1: / Line 1: @@
 ==Differentiating Leukocytosis from Other Diseases==
-*Leukocytosis is defined as an elevated white blood cell (WBC) count greater than 11,000 per mm3 (11.0 × 109 per L).
-*The most common type of leukocytosis is neutrophilia.
-**Neutrophilia can be defined as an increase in the absolute number of mature neutrophils to greater than 7,000 per mm3 [7.0 × 109 per L].
 {|
 ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
@@ Line 24: / Line 20: @@
 |-
 ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
-! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |increased bone marrow production
+! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Increased bone marrow production
-! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |demargination of peripheral blood neutrophils
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
 ! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
 ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
@@ Line 32: / Line 28: @@
 ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
 ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
-!
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
-!
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
 ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
 ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
@@ Line 39: / Line 35: @@
 ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
 ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
-! rowspan="2" |BUN/Cr
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
-! rowspan="2" |LFT
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
 |-
-!autonomous
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous
-!reactive
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive
-!Lymphadenopathy
-!Joint redness
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
@@ Line 51: / Line 45: @@
 |-
 ! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematologic
-! align="center" style="background:#DCDCDC;" |Hereditary neutrophilia
+! align="center" style="background:#DCDCDC;" |[[Granulocytosis|Hereditary neutrophilia]]
+| align="center" style="background:#F5F5F5;" + |
+* Unknown
+* Germline mutation in [[CSF3R]]
+| align="center" style="background:#F5F5F5;" + | -
+| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + | --
+| align="center" style="background:#F5F5F5;" + | -
+| align="center" style="background:#F5F5F5;" + | +
+| align="center" style="background:#F5F5F5;" + | -
+| align="center" style="background:#F5F5F5;" + |Rare [[Dominance relationship|autosomal dominant]] genetic disorder
+| align="center" style="background:#F5F5F5;" + |
+* Positive family history
+| align="center" style="background:#F5F5F5;" + |Normal
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |+
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |-
+| align="center" style="background:#F5F5F5;" + |↑
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |
+* Normal [[Granulocyte|granulocytes]]
+* [[Histiocyte|Histiocytes]] of Gaucher type
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |Nl
+| align="center" style="background:#F5F5F5;" + |[[Genetics|Genetic]] study
+| align="center" style="background:#F5F5F5;" + |
+* High [[leukocyte alkaline phosphatase]]
+* Progress to [[leukemia]]
+|-
+! align="center" style="background:#DCDCDC;" |Hereditary chronic neutrophilia
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 67: / Line 102: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 76: / Line 109: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |'''Hereditary chronic neutrophilia'''
+! align="center" style="background:#DCDCDC;" |[[Myeloproliferative neoplasm|Myeloproliferative neoplasms]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 97: / Line 132: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 106: / Line 139: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |'''Myeloproliferative neoplasms'''
+! align="center" style="background:#DCDCDC;" |[[Polycythemia vera]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 127: / Line 162: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 136: / Line 169: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Polycythemia Vera
+! align="center" style="background:#DCDCDC;" |[[Microangiopathic hemolytic anemia]] (MAHA)
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 157: / Line 192: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 166: / Line 199: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |'''Microangiopathic hemolytic anemia (MAHA)'''
+! align="center" style="background:#DCDCDC;" |Leukoerythroblastosis
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 187: / Line 222: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 196: / Line 229: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-!'''Leukoerythroblastosis'''
+! align="center" style="background:#DCDCDC;" |Immune thrombocytopenia
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-!
-|-
-! align="center" style="background:#DCDCDC;" |Immature thrombocytopenia
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 247: / Line 252: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 256: / Line 259: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 266: / Line 267: @@
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
-!Autonomous increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
-!Reactive increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
-!demargination of peripheral blood neutrophils
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
@@ Line 279: / Line 280: @@
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
-!Lymphadenopathy
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
-!Joint redness
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
@@ Line 288: / Line 289: @@
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
-!BUN/Cr
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
-!LFT
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
 |-
-!'''Leukocyte adhesion deficiency'''
+! align="center" style="background:#DCDCDC;" |[[Leukocyte adhesion deficiency]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!'''Cryopyrin-associated periodic syndromes'''
+! align="center" style="background:#DCDCDC;" |Cryopyrin-associated periodic syndromes
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Rheumatoid arthritis
+! align="center" style="background:#DCDCDC;" |[[Rheumatoid arthritis]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 369: / Line 374: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 378: / Line 381: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Juvenile onset rheumatoid arthritis
+! align="center" style="background:#DCDCDC;" |[[Juvenile rheumatoid arthritis|Juvenile onset rheumatoid arthritis]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 399: / Line 404: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 408: / Line 411: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-!adult Still's disease
+! align="center" style="background:#DCDCDC;" |[[Still's disease|Adult Still's disease]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!Kawasaki disease
+! align="center" style="background:#DCDCDC;" |[[Kawasaki disease]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |IBD
+! align="center" style="background:#DCDCDC;" |[[Inflammatory bowel disease|IBD]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 489: / Line 494: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 498: / Line 501: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-!Sarcoidosis
+! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Chronic hepatitis
+! align="center" style="background:#DCDCDC;" |[[Hepatitis|Chronic hepatitis]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 549: / Line 554: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 558: / Line 561: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-!Sweet syndrome
+! align="center" style="background:#DCDCDC;" |[[Sweet's syndrome|Sweet syndrome]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Acute Gout
+! align="center" style="background:#DCDCDC;" |[[Gout|Acute gout]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 609: / Line 614: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 618: / Line 621: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! rowspan="5" |Infections
+! rowspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection
-! align="center" style="background:#DCDCDC;" |Acute bacterial
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
+|-
+! align="center" style="background:#DCDCDC;" |[[Infection|Acute bacterial]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 640: / Line 673: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 649: / Line 680: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
+| align="center" style="background:#F5F5F5;" + |
-|
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Chronic
+! align="center" style="background:#DCDCDC;" |[[Infection|Chronic infection]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 670: / Line 705: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 679: / Line 712: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-!Viral infection
+! align="center" style="background:#DCDCDC;" |[[Infection|Viral infection]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!Children
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!granulomatous infections
+! align="center" style="background:#DCDCDC;" |[[Granuloma|Granulomatous]] infections
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!bronchiectasis
+! align="center" style="background:#DCDCDC;" |[[Bronchiectasis]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-! rowspan="5" |Metabolic
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Metabolic
-!Diabetic coma
+! align="center" style="background:#DCDCDC;" |[[Diabetic coma]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!Acidosis
+! align="center" style="background:#DCDCDC;" |[[Acidosis]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!Thyroid strom
+! align="center" style="background:#DCDCDC;" |[[Thyroid storm]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!Hypercortisolism
+! align="center" style="background:#DCDCDC;" |[[Cushing's syndrome|Hypercortisolism]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!Seizures
+! align="center" style="background:#DCDCDC;" |[[Seizure|Seizures]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
+! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medication
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
@@ Line 941: / Line 972: @@
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Jaundice
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
 |-
-! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medications
+! align="center" style="background:#DCDCDC;" |[[Steroid|Steriod]]
-! align="center" style="background:#DCDCDC;" |Steriod
+| align="center" style="background:#F5F5F5;" + |
-| align="center" style="background:#F5F5F5;" + |Release of granulocytes from the bone marrow
+* Release of granulocytes from the bone marrow
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 973: / Line 1,008: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 982: / Line 1,015: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-!myeloid growth factors
+! align="center" style="background:#DCDCDC;" |Myeloid growth factors
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Lithium
+! align="center" style="background:#DCDCDC;" |[[Lithium]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,033: / Line 1,068: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,042: / Line 1,075: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Beta agonists
+! align="center" style="background:#DCDCDC;" |[[Cytokine|Cytokines]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,063: / Line 1,098: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,072: / Line 1,105: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Cytokines
+! align="center" style="background:#DCDCDC;" |[[Catecholamine|Catecholamines]] ([[epinephrine]])
+| align="center" style="background:#F5F5F5;" + |
+* Stimulation of bone marrow myelopoiesis
+* Egress into the circulation
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,093: / Line 1,130: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,102: / Line 1,137: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-!Catecholamines (epinephrine)
+! align="center" style="background:#DCDCDC;" |[[Tretinoin|ATRA]]
-|Stimulation of bone marrow myelopoiesis and/or egress into the circulation
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!ATRA
+! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
 |-
-! rowspan="9" |Other
+! align="center" style="background:#DCDCDC;" |[[Allergy]]
-!Allergy
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
 |-
-! align="center" style="background:#DCDCDC;" |Post splenectomy
+! align="center" style="background:#DCDCDC;" |Post [[splenectomy]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,214: / Line 1,251: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,223: / Line 1,258: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Down syndrome
+! align="center" style="background:#DCDCDC;" |[[Down syndrome]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,244: / Line 1,281: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,253: / Line 1,288: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-!Cigarette smoking
+! align="center" style="background:#DCDCDC;" |[[Smoking|Cigarette smoking]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!'''Stress/Exercise'''
+! align="center" style="background:#DCDCDC;" |[[Stress (medicine)|Stress]]/[[Physical exercise|exercise]]
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Infancy
+! align="center" style="background:#DCDCDC;" |[[Infant|Infancy]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,334: / Line 1,371: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,343: / Line 1,378: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-! align="center" style="background:#DCDCDC;" |Pregnancy
+! align="center" style="background:#DCDCDC;" |[[Pregnancy]]
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
+| align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,364: / Line 1,401: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
@@ Line 1,373: / Line 1,408: @@
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
-|
-|
 | align="center" style="background:#F5F5F5;" + |
 | align="center" style="background:#F5F5F5;" + |
 |-
-!Platelet clumping
+! align="center" style="background:#DCDCDC;" |[[Platelet]] clumping
-!Spurious
+| align="center" style="background:#F5F5F5;" + |Spurious
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
-!Mixed cryoglobulinemia
+! align="center" style="background:#DCDCDC;" |[[Cryoglobulinemia|Mixed cryoglobulinemia]]
-!Spurious
+| align="center" style="background:#F5F5F5;" + |Spurious
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
-!
+| align="center" style="background:#F5F5F5;" + |
 |-
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
@@ Line 1,442: / Line 1,475: @@
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physiologic
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autonomous increased bone marrow production
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Reactive increased bone marrow production
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demargination of peripheral blood neutrophils
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried
@@ Line 1,453: / Line 1,486: @@
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Splenomegaly
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Asplenia
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Jaundice
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint redness
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other signs
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HB
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PBS
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow exam
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
 |}
-<references />

Sandbox: wdx causes: Difference between revisions

Latest revision as of 21:38, 17 September 2018

Differentiating Leukocytosis from Other Diseases

Navigation menu